期刊
NATURE REVIEWS DRUG DISCOVERY
卷 6, 期 3, 页码 189-201出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd2217
关键词
-
资金
- Medical Research Council [MC_U138135973] Funding Source: Medline
- MRC [MC_U138135973] Funding Source: UKRI
- Medical Research Council [MC_U138135973] Funding Source: researchfish
Psychiatric disorders such as depression, anxiety and schizophrenia are leading causes of disability worldwide, and have a huge societal impact. However, despite the clear need for better therapies, and major advances in the understanding of the molecular basis of these disorders in recent years, efforts to discover and develop new drugs for neuropsychiatric disorders, particularly those that might revolutionize disease treatment, have been relatively unsuccessful. A multidisciplinary approach will be crucial in addressing this problem, and in the first Advances in Neuroscience for Medical Innovation symposium, experts in multiple areas of neuroscience considered key questions in the field, in particular those related to the importance of neuronal plasticity. The discussions were used as a basis to propose steps that can be taken to improve the effectiveness of drug discovery for psychiatric disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据